Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)

A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension

This study will explore the dose-response of losartan as well as the safety and tolerability in children from 6 months to 6 years of age.

Inclusion Criteria:

• Participant is determined to be hypertensive

Exclusion Criteria:

• Participant has a history of severe or symptomatic hypertension
• Participant has history of heart failure, rhythm disturbance or cardiomyopathy, or obstructive valvular disease
• Participant has started taking hypertensive medications within the past 30 days
• Participant has a known sensitivity to losartan or history of angioneurotic edema